Debra Reisenthel
Debra Reisenthel "has more than 25 years experience in the health care industry, primarily focused on women's and children's health. She has led Novasys Medical as President and CEO since 2001, from the company’s early stages of animal studies, human clinicals and FDA clearance to the commercialization of the Renessa procedure. She has funded the company’s progress through three rounds of financing with leading medical device venture investors. Based on her fundraising success, she was asked to author a chapter entitled "The Fundraising Process: A CEO's Perspective" in Inside the Minds: Raising Capital for Health Care Companies. Prior to Novasys, Debra was Vice President and General Manager of Tyco Healthcare, Nellcor division, for more than 10 years leading the entrepreneurial perinatal business. She provided leadership and vision for the development and commercialization of the division's key product, a breakthrough technology for non-invasive oxygen monitoring of the fetus during labor and delivery. Debra commenced her career as a clinical specialist at Loyola Medical Center in Chicago. She holds a BA, an AS in Respiratory Care (CRTT, RRT), and an MBA. Debra is a leader in numerous professional organizations, including as a member of the Advisory Board to the Professional Women's Healthcare Alliance." [1]
Resources and articles
Related Sourcewatch articles
References
- ↑ Leadership, Novasys Medical, accessed August 31, 2008.